Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-8,843
Closed -$911K 191
2024
Q4
$911K Sell
8,843
-9,410
-52% -$1.03M 0.03% 138
2024
Q3
$2.04M Buy
+18,253
New +$1.86M 0.06% 116
2023
Q4
Sell
-35,864
Closed -$2.75M 174
2023
Q3
$2.75M Buy
35,864
+15,116
+73% +$1.12M 0.12% 103
2023
Q2
$1.45M Buy
20,748
+19,068
+1,135% +$1.28M 0.06% 116
2023
Q1
$108K Buy
+1,680
New +$115K 0.01% 169
2021
Q4
Sell
-18,060
Closed -$941K 200
2021
Q3
$941K Hold
18,060
0.16% 112
2021
Q2
$969K Buy
+18,060
New +$985K 0.09% 195
2019
Q1
Sell
-2,227
Closed -$100K 527
2018
Q4
$100K Hold
2,227
0.01% 327
2018
Q3
$104K Buy
+2,227
New +$102K 0.01% 381
2013
Q3
Sell
-1,960
Closed -$57K 244
2013
Q2
$57K Buy
+1,960
New +$53.2K ﹤0.01% 229

Other funds holding AFL

Meag Munich Ergo's AFL Position: Q1 2025 in Review

Meag Munich Ergo sold out of Aflac (AFL) in Q1 2025, closing a stake of 8,843 shares — an estimated $911K sold.

Meag Munich Ergo first reported a position in AFL in Q2 2013 and held it in 10 quarters. The position peaked at $2.75M in Q3 2023. 1,628 funds tracked by Wall St. Rank hold AFL as of Q1 2025.

  • Meag Munich Ergo reported no remaining Aflac position as of Q1 2025 after selling out during the quarter.
  • Meag Munich Ergo sold 8,843 Aflac shares in Q1 2025, an estimated $911K.
  • Meag Munich Ergo first reported a position in Aflac in Q2 2013 and held it in 10 quarters.
  • Meag Munich Ergo's Aflac position peaked at $2.75M in Q3 2023.
  • 1,628 funds tracked by Wall St. Rank held Aflac as of Q1 2025.

Based on Meag Munich Ergo's 13F filing for Q1 2025, filed 17 Apr 2025.